Lovastatin-induced PC-12 cell differentiation is associated with RhoA/RhoA kinase pathway inactivation

Carlos Fernández-Hernando1, Yajaira Suárez, Miguel A Lasunción

  • 1Servicio de Bioquímica-Investigación, Hospital Ramón y Cajal, Madrid, Spain.

Insights

Inhibiting cholesterol synthesis promotes neurite outgrowth by affecting protein prenylation and RhoA signaling. This sterol-dependent process involves the regulation of cellular lipid composition in neuroblasts.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Cellular lipid composition's role in neuroblast neurite outgrowth is poorly understood.
  • Cholesterol and non-sterol isoprenoids are critical cellular lipids.

Purpose of the Study:

  • Investigate the role of cholesterol and non-sterol isoprenoids in neurite outgrowth.
  • Elucidate the molecular mechanisms regulating neurite extension in PC-12 cells.

Main Methods:

  • Utilized inhibitors of cholesterol biosynthesis targeting different pathway points.
  • Assessed neurite outgrowth in PC-12 cells.
  • Analyzed RhoA activation, Cofilin phosphorylation, and protein prenylation.

Main Results:

  • Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase induced sterol-dependent neurite outgrowth.
  • Non-sterol mevalonate derivatives and geranylgeraniol blocked this effect, suggesting protein prenylation involvement.
  • Lovastatin inhibited RhoA activation and Cofilin phosphorylation; geranylgeraniol reversed these.
  • Geranylgeraniol's effect was blocked by Y-27632, indicating RhoA kinase mediation.

Conclusions:

  • Inhibition of geranylgeraniol synthesis drives sterol-dependent neurite outgrowth.
  • This process is mediated by the inhibition of RhoA signaling pathways.
  • Protein prenylation plays a regulatory role in neurite outgrowth.